An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage

Sci Rep. 2023 Jul 20;13(1):11702. doi: 10.1038/s41598-023-38890-4.

Abstract

Ultraviolet radiation (UVR) induces immunosuppression and DNA damage, both of which contribute to the rising global incidence of skin cancer including melanoma. Nucleotide excision repair, which is activated upon UVR-induced DNA damage, is linked to expression of interleukin-12 (IL-12) which serves to limit immunosuppression and augment the DNA repair process. Herein, we report an immunomodulating peptide, designated IK14800, that not only elicits secretion of IL-12, interleukin-2 (IL-2) and interferon-gamma (IFN-γ) but also reduces DNA damage in the skin following exposure to UVR. Combined with re-invigoration of exhausted CD4+ T cells, inhibition of UVR-induced MMP-1 release and suppression of B16F10 melanoma metastases, IK14800 offers an opportunity to gain further insight into mechanisms underlying the development and progression of skin cancers.

MeSH terms

  • DNA Damage
  • DNA Repair
  • Humans
  • Immunosuppression Therapy / adverse effects
  • Interleukin-12
  • Melanoma* / etiology
  • Skin Neoplasms* / complications
  • Ultraviolet Rays / adverse effects

Substances

  • Interleukin-12